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ABSTRACT 
The human immunodeficiency virus type 1 Aspartic protease (HIV-1 PR) is an 
important enzyme due to its vital role in viral maturation. Inactivation of the enzyme 
causes the production of immature viral particles. The accurate prediction of enzyme-
substrate interaction energies is one of the major challenges in computational biology. 
Docking experiments were undertaken using the programs AutoDock.4 and online 
programs pardock for twenty-five HIV-1 protease-inhibitor complexes determined by x-ray 
crystallography. From the molecular docking study, we were able to select a best solution 
based on lowest binding energy and lowest RMSD values of receptor-ligand complex in 
each docking program.  
   Correlations observed for experimental and predicted binding energy values for 
receptor-ligand complex. A highest correlation coefficient of 0.801 was observed between 
the experimental and predicted binding energy for pardock program and 0.484 by autodock 
4.0. Patch dock followed by firedock methods also used to predict the global energy of 
each enzyme-inhibitor complex and complementarily score. Our result indicates that the 
binding energies predicted by pardock program are highly correlated with experimental 
binding energies. The consensus ranking of enzyme-inhibitor complexes in various 
molecular docking methods improve the binding energy predictions. Consensus ranking 
has become an important method in various molecular docking methods to identify new 
inhibitors in computer-assisted discovery of new pharmaceutics. 
Keywords: HIV-1Protease, Computer Assisted Drug Design, Molecular docking, 
Autodock4.0, Pardock. 
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1.1 Human immunodeficiency virus (HIV) 
 It has now been two decades since acquired immunodeficiency syndrome (AIDS) was first 
reported by the US Center for Diseases Control (CDC). A few years later, it was found that 
a retrovirus called human immunodeficiency virus (HIV) is the causative agent in AIDS 
[1]. Since the outbreak of the AIDS epidemic, tremendous efforts directed towards 
development of antiretroviral therapies that target HIV type 1 in particular (HIV-1). Critical 
step in the life cycle of HIV is the proteolytic cleavage of the polypeptide precursors into 
mature enzymes and structural proteins catalyzed by HIV PR. It has been shown that 
budded immature viral particles that contain catalytically inactive protease cannot undergo 
maturation to an infective Form.2 The necessity of this enzyme in the virus life cycle 
makes it a promising target for therapy of the HIV infection[3]. 
1.2 HIV-1 Protease: HIV protease: a logical target for AIDS therapy 
Highly conserved catalytic sequence: Asp-Thr-Gly (25-26-27) in each monomer [8]. That 
constitutes in part the substrate-binding site and plays an important role in substrate 
binding, and one of the two essential Aspartyl residues, Asp-25 and Asp-25 that lie on the 
bottom of the cavity. The substrate binds in its extended conformation, in which its 
interactions with the different amino acid side chains determine the specificity of the 
enzyme [7].  The two S1 subsites are very hydrophobic; the S2 subsites are mostly 
hydrophobic except Asp-29, Asp-29_, Asp-30 and Asp-30. The S3 subsites are adjacent to 
S1 subsites and are mostly hydrophobic.  Antiretroviral drugs are developed for 
inactivation of hiv-1 protease. The accurate prediction of enzyme-substrate interaction 
energies is one of the major challenges in computational biology. For this, various docking 
methods have been developed with different force field parameters and scoring functions. 
1.3 PDB files 
HIV-1 protease-inhibitor complexes taken from Protein Data Bank in the form of PDB 
format. Since our interests are concentrated on small non-covalently bound ligands, those 
complexes containing covalently bound ligands, complex ligands and macromolecular 
ligands are stripped out of the data set.UCSF Chimera is a highly extensible, interactive 
molecular visualization and analysis system. Chimera can read molecular structures and 
associated data in a large number of formats, display the structures in a variety of 
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representations, and generate high-quality images and animations suitable for publication 
and presentation. Separated protein file and ligand file by gripping from protein-ligand 
complex. 
Binding free energy was determined by differences in enthalpy and entropy of the free and 
bound state. The binding constant Ki assuming thermodynamic equilibrium conditions for 
the protein-ligand complex formation quantifies usually binding affinity.  Given recent 
improvements in search algorithms and energy functions, computational docking methods 
have become a valuable tool to probe the interaction between an enzyme and its inhibitors. 
These methods can contribute significantly to the understanding of structural and energetic 
basis of enzyme-substrate interactions. Protein-ligand docking methods aim to predict the 
binding energy of the protein-ligand complex given the atomic coordinates. A set of HIV-1 
protease-inhibitor binding energies were determined by various docking methods. 
1.4 Protein-ligand interactions 
 Hydrogen bonds (e.g. C=O ... H-N): Hydrogen bonding is no doubt one of the key 
features for a specific binding process. Such interaction may happen when two atoms get 
close enough and form a donor-acceptor pair. 
Hydrophobic interaction:  --CH3------CH3----- 
Hydrophobic Patch on the Inside of the Flap. Ile-47, Ile-54 and Val-56 are involved in 
hydrophobic interactions, With Ile-47 sitting just above Val-32 in the hydrophobic. 
Desolvation effect: Since both the protein and its ligand are solvated before complexation, 
the protein-ligand binding process was accompanied by desolvation, which undergoes 
changes in entropy as well as in enthalpy. This kind of effect is very difficult to 
characterize accurately. Both the long-range “Hydrophobic effect” and specific hydrogen 
bondings of water could be important in elucidation. These features make it nameable to 
simple additive pair wise interactions. So far, this effect was measured by calculating the 
buried hydrophobic surface areas during the binding process.  
Van der Waals (VDW) interaction: This kind of interaction is a balance between 
attractive dispersion force and short-range repulsion. Although it was well accepted that 
van der Waals interactions play a fundamental role in the binding of the protein and its 
ligand, arguments exist in how to represent it in calculating the binding affinity. Some 
researchers assume that protein-ligand, protein-solvent, and ligand-solvent interfaces are 
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well packed and hence neglect any change in the VDW interactions upon binding. Some 
others assume that VDW interactions are better in a complex and therefore explicitly 
include them. By analyzing the training set, we believe that they all tell only part of the 
story. In general, one will find a closely packed interaction interface in a protein, ligand 
complex where many atom pairs are in a distance much shorter than the sum of their VDW 
radii, i.e. they form VDW bumps. Not all of these bumps come from hydrogen bonding or 
other strong interactions. Some of them are just the result of the tight binding between 
other parts of the protein and its ligand. It is not reasonable to assume that such a situation 
can also be found on the protein-solvent or ligand-solvent interface where the water 
molecules are mobile. Thus, our conclusion is that the VDW attraction between the protein 
and its ligand neglected due to the competitive interaction with water in the unbound state 
while, the VDW repulsion cannot. In the algorithms, the term for VDW interaction is 
simply a pair wise counting of VDW bumps between the protein and the ligand. 
Metal-ligand bonding: 
 A variety of proteins have metal cations in their active sites, such as Mg2+, Ca2+, Mn2+, 
and Zn2+. In such cases, coordinate bonding between the metal and the ligand can often be 
important. 
Deformation effect: Deformation refers to the conformational changes during the binding 
process. On one hand, it causes adverse entropic changes due to the freezing of internal 
rotations of both the protein and its ligand; on the other hand, it causes adverse enthalpy 
change due to the strain energy exerted during binding. Based on the principles of 
statistical thermodynamics, the entropic changes usually estimated by using a constant 
value per rotatable bond that is frozen. However, the enthalpy change is more difficult to 
elucidate. 
1.5 Binding energy  
Gibbs free energy of binding is ∆G then related to the binding constant by ∆G0=-RTlnKi  
At best, ∆G is determined by statistical thermodynamics resulting in a master equation that 
considers all contributing effects. More recently, empirical schemes have met with 
significant interest. The basic assumption underlined in such approaches is that the overall 
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binding free energy can be decomposed into components. This can be written out 
conceptually by the following equation. 
                ∆GBinding= ∆GMotion+ ∆GInteraction+ ∆GSolvent+ ∆GCofiguration 
The parameters in the equation are often determined from binding data in a statistical 
manner. This kind of approach is also referred to as “Master Equation”. Computationally 
top-scoring solutions taken a selection from among the top scoring solution (e.g. the one 
closest to the experimental data among the ten top solutions) or simply the solution closest 
to the experimental data[40] (easiest and least rigorous approach). The accurate prediction 
of enzyme-substrate interaction energies is one of the major challenges in computational 
biology. Generally various docking methods followed by various energy scoring functions. 
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2.1 Targeting HIV-1 protease  
The human immunodeficiency virus type 1 aspartic protease (HIV-1 PR) is an important 
enzyme due to its vital role in viral maturation. Inactivation of the enzyme causes the 
production of immature viral particles. The accurate prediction of enzyme-substrate 
interaction energies is one of the major challenges in computational biology [1].  
The enzyme therefore is an attractive target in anti-AIDS drug design, and the effect of 
binding various inhibitors on the protease, structure is currently the focus of intensive 
research. To obtain information about the position and energy of binding between an 
inhibitor and the corresponding protein, several automated docking programs have been 
developed (Ram Samudrala et al., 2003). 
2.2 Motivation 
According to (Ram Samudrala et al., 2003) improved the prediction of HIV-1 protease-
inhibitor binding energies by molecular dynamics simulations than prediction of binding 
energies without any molecular dynamics simulations [1]. However, in computational 
biology using molecular dynamics simulation supercomputing facilities are needed. This 
computational method takes time-consuming process. We have focused on this method, 
and applied various molecular docking methods to predict the binding energies between 
hiv-1 protease-inhibitors. 
One of these targets is HIV-1 protease (HIV PR), an essential enzyme needed in the proper 
assembly and maturation of infectious virions. Understanding the chemical mechanism of 
this enzyme has been a basic requirement in the development of efficient inhibitors.  
 
2.3 The life cycle of HIV 
HIV belongs to the class of viruses called retroviruses, which carry genetic information in 
the form of RNA. HIV infects T cells that carry the CD4 antigen on their surface. The 
infection of the virus requires fusion of the viral and cellular membranes, a process that 
mediated by the viral envelope Glycoprotein (gp120, gp41) and receptors (CD4 and co 
receptors, such as CCR5 or CXCR4) on the target cell. As the virus enters a cell, its RNA is 
reverse-transcribed to DNA by a virally encoded enzyme, the reverse transcriptase (RT). 
The viral DNA enters the cell nucleus, where it integrated into the genetic material of the 
cell by a second virally encoded enzyme, the integrase. Activation of the host cell results in 
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the transcription of the viral DNA into messenger RNA, which then translated into viral 
proteins. HIV protease, the third virally encoded enzyme, is required in this step to cleave a 
viral polyprotein precursor into individual mature proteins [2]. The viral RNA and viral 
proteins assemble at the cell surface into new virions, which then bud from the cell and 
released to infect another cell. The extensive cell damage from the destruction of the host’s 
genetic system to the budding and release of virions leads to the death of the infected cells 
[2]. 
2.4 Structure of HIV protease 
Navia et al. from Merck laboratories were the first group to obtain a crystal structure of 
HIV PR [4]. Kent and coworker reported a more accurate structure subsequently [5]. HIV 
PR is a 99 amino acid Aspartyl protease that functions as a homodimer with only one active 
site, which is C2-symmetric in the free form. More than 140 structures of the HIV-1 PR, its 
mutants and enzymes complexed with various inhibitors reported so far. A database 
dedicated to providing structural information about HIV PR created at the National Cancer 
Institute (http://www-fbsc.ncifcrf.gov/HIVdb). The enzyme homodimer complexed with 
TL-3[6] shown in Fig.1 (PDB ID: 3TLH). Each monomer contains an extended β-sheet 
region (a Glycine-rich loop) known as the flap, that constitutes in part the substrate-binding 
site and plays an important role in substrate binding, and one of the two essential Aspartyl 
residues, Asp-25 and Asp-25_ which lie on the bottom of the cavity. The substrate binds in 
its extended conformation, in which its interactions with the different amino acid side 
chains determine specificity of the enzyme [7].  
Fig.1 Structure of HIV PR complexed with TL-3 (PDB: 3TLH). 
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Fig. 2 Standard nomenclature P1 __ Pn, P1__ Pn  used to designate amino acid residues of 
peptide substrates. The corresponding binding sites on the protease are referred to as S1 _  
Sn, S1__ Sn subsites.                                                Fig.3: TL-3inhibitor  
                      
 
2.5 Active site 
Highly conserved catalytic sequence: Asp-Thr-Gly (25-26-27) in each monomer [8].Thr is 
buried in active site. Asp is essential to PR both catalytically and structurally Asp25 (25’) 
induces a general acid/ base protein hydrolysis. The dimeric structure, in which each 
monomer contributes one Asp-Thr-Gly triad to the pseudo-symmetric active site, shows an 
active site that is indistinguishable from those of the monomer Aspartic 
proteases.However,the results from most of these studies are consistent with general acid–
base mechanism, in which the two active site Aspartate residues play an essential general 
acid–base role to activate the water molecule that acts as a nucleophile and attacks the 
carbonyl carbon of the scissile bond. It was generally believed that this water molecule is 
located between the active site Aspartates, although some have suggested a different 
nucleophilic water molecule. 
2.6 Secondary structure  
HIV PR is a 99 amino acid Aspartyl protease, which functions as a homodimer with only 
one active site, which is C2-symmetric in the free form. More than 140 structures of the 
HIV-1 PR, its Each monomer contains an extended β-sheet region (a Glycine-rich loop) 
known as the flap, that constitutes in part the substrate-binding site and plays an important 
role in substrate binding, and one of the two essential Aspartyl residues, Asp-25 and Asp-
25’ which lie on the bottom of the cavity. 
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Fig.4: One monomer of HIV-1 PR               Fig.5: Dimer of HIV-1PR 
                            
 
 
 
 
 
 
 
2.7 Mechanism of the HIV protease 
Proteases are known to play essential roles in many biological processes. They catalyze the 
hydrolysis of peptide bonds with high sequence selectivity and catalytic proficiency. These 
enzymes accomplish their catalysis by two different mechanisms, thus dividing them 
mechanistically into two broad classes of protease enzymes. The first class of enzymes uses 
an activated water molecule to attack the amide bond carbonyl of the substrate’s scissile 
bond. The activation of the water molecule can be achieved either by a zinc cation (the zinc 
metalloproteinase’s) or by the two-Aspartyl β-carboxy groups at the active site (the 
Aspartate proteases). In the second class of proteases, a nucleophilic atom of an amino acid 
side chain is used to initiate amide hydrolysis. In the first step the nucleophilicatom, which 
can be a hydroxyl group or a thiol, is activated by another amino acid side chain. The 
activated nucleophile attacks the carbonyl of the scissile amide bond to form an ester or a 
thioester acyl intermediate. Eventually, a water molecule to the corresponding hydrolysis 
products hydrolyzes this acyl enzyme intermediate. According to several studies, HIV PR 
in general has been shown to belong to the class of the Aspartic proteases. Examining the 
sequence homology of HIV PR to other cellular Aspartic proteases shows that this enzyme 
has the sequence Asp-Thr-Gly, which is conserved among the Aspartic protease enzymes 
[8]. These results suggested that HIV PR-1 enzyme might have similar structural features 
to the Aspartic protease enzymes as well as a similar mechanism. Indeed, mutational 
analysis by several groups of the highly conserved Asp- 25 has shown that substituting this 
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residue with Asn [2, 9], Thr [10] or Ala [11] leads to a protein without any proteolytic 
activity. More support for HIV PR being a member of the Aspartic protease family came 
from the in vitro inhibition of this enzyme by pepstatin, a natural product that selectively 
inhibits members of this family [9, 10, 12]. Finally, the Three-dimensional structure of this 
enzyme also supported the classification of HIV PR in the Aspartic protease family [4, 5, 
13].The dimeric structure, in which each monomer contributes one Asp-Thr-Gly triad to the 
pseudo-symmetric active site, shows an active site that is indistinguishable from those of 
the monomeric Aspartic proteases. Kinetic methods, affinity labeling and X-ray 
crystallography have extensively studied the catalytic mechanism of the non-viral Aspartic 
proteases. Several mechanisms of action for this family proposed, including a mechanism 
that involves the formation of a covalent intermediate.  
 
2.7.1 Catalytic mechanism for HIV 
Fig.2 Standard nomenclature P1 __ Pn, P1__ Pn is used to designate amino acid residues of 
peptide substrates. The corresponding binding sites on the protease are referred to as S1 _ 
Sn, S1_ Sn_ subsites. general acid–base mechanism, in which the two active site Aspartate 
residues play an essential general acid–base role to activate the water molecule that acts as 
a nucleophile and attacks the carbonyl carbon of the scissile bond. It is generally believed 
that this water molecule is located between the active site Aspartates, although some have 
suggested a different nucleophilic water molecule [15]. The most widely accepted 
mechanism for Aspartic protease has been described by Suguna et al. (Fig. 3)[16]. The 
proposed mechanism is based on the crystal structure of the Rhizopys chinensis Aspartic 
protease complexed with a reduced peptide inhibitor. The pH–rate profile of this enzyme 
implies that only one of the two active site Aspartic acids is unprotonated in the active pH 
range [17]. In the proposed mechanism, the Asp group that is closer to the nucleophilic 
water molecule was assigned the negative charge (Fig.3). The nucleophilic water molecule 
held between the catalytic Aspartates, after its activation by the negative Aspartate side 
chain, attacks the carbonyl group in the substrate scissile bond to generate an oxyanion 
tetrahedral intermediate. Protonation of the scissile amide N atom and rearrangement result 
in the breakdown of the tetrahedral intermediate to the hydrolysis products. This general 
acid–base mechanism of the Aspartic protease family precludes the use of a Lewis acid 
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such as Zn+2(as in the case of zinc metalloproteinase) and the formation of covalent acyl 
intermediates [14, 18]. Although the HIV PR mechanism shares many features with the rest 
of the Aspartic protease family, the full detailed mechanism of this enzyme remains not 
fully understood. Jaskólski et al. have proposed a new model of the enzymatic mechanism 
for the HIV PR enzyme based on the crystal structure of a complex between a chemically 
synthesized HIV PR and an octapeptide inhibitor U-85548e (H-Val-Ser-Gln-Asn-Leu-ψ-
[CH(OH)- CH2]-Val-Ile-Val-OH)[19]. As well as other crystal structures of HIV PR 
complexed with different inhibitors [20] in this mechanism (Fig.6). The hydrolysis reaction 
is viewed as a one-step process during which the nucleophilic water molecule and the 
acidic proton attack the scissile peptide bond in a concerted manner. The issue of the 
simultaneous attack from the nucleophile and electrophile is the major difference between 
this mechanism and other previously proposed mechanisms. As in the case of all the 
Aspartic protease family, the possibility of covalent catalysis (e.g. Asp-25 attacks directly 
the carbonyl amide bond) in the chemical mechanism of HIV PR is discounted. Indeed, 
Hyland et al. have provided evidence against the formation of a covalent intermediate by 
studying 
 
Fig.6: Proposed concerted catalytic mechanism for HIV. 
 
 It has been suggested that the protonation state of the two-Aspartic groups depends on the 
local environment near the Aspartate and is different for different inhibitors [19, 23]. 
However, it has been suggested also that the difference in pKas of these residues is more a 
function of their proximity to each other than of their differing environments [13, 24]. 
Aspartic proteases are unique in that they function physiologically over a wide pH range 
(2–7.4)[17]. The pH–rate profile of a model substrate for HIV PR studied by Meek and 
coworker shows that the two Aspartate groups have different pKa values of 3.1 and 5.2[25]. 
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In contrast to these results, Smith et al. have found in their NMR experiments on the 13C-
enriched enzyme in the absence of inhibitor, that the two Asp side chains are Fig.6 
Proposed concerted catalytic mechanism for HIV. Equivalent and are both deprotonated at 
pH 6[26]. However, in the presence of pepstatin inhibitor only one Asp side chain is 
deprotonated in the pH range 2.5–6.5. Wang et al. have also examined the protonation state 
of the two-Aspartic groups, however using the asymmetric inhibitor KNI-272[27]. They 
also found one catalytic Asp to be protonated and the other unprotonated. In contrast to 
these results, Yamazaki et al. have Studied the ionization state of the two-Aspartic groups 
in HIV PR complexed with the symmetric inhibitor DM323[28]. This non-peptidic 
inhibitor contains two hydroxyl groups and forms a completely symmetric complex with 
the enzyme, in which the side chains of the two Aspartates were found to be magnetically 
equivalent and both protonated over the pH range 2–7. Using ab initio molecular dynamics 
studies of the pepstatin A–HIV PR complex, Piana et al. have proposed recently that both 
Aspartic groups are protonated [29] in contrast to what had been reported by Smith et al 
[26]. An answer to the question of where the acidic proton is located in the free enzyme 
could not be easily provided since proton locations are generally not resolvable by X-ray 
crystallography methods [16, 19] Meek et al. have shown that the known Aspartic protease 
inactivate 1, 2-epoxy-3-(4-nitrophenoxy) propane produced irreversible, time-dependent 
inactivation of HIV PR, Through covalent modification of the enzyme’s Aspartyl residue 
[30]. The PH-dependent kinetics of this inhibitor–enzyme interaction was consistent with 
having one protonated Aspartic group in the active site of the enzyme. Following this 
observation, Lee and Coworkers [31] have designed several inhibitors based on a peptide 
isostere containing cis-epoxide for the irreversible inactivation of HIV.These results are 
surprising, since one would expect the catalytic water molecule to be involved in the 
epoxide ring opening instead of direct attack by the Aspartyl group. Perhaps the alignment 
of the inhibitor in the active site does not allow enough space between the epoxide ring and 
the two-Aspartyl residues to accommodate a water molecule. Hyland et al. have proposed a 
detailed chemical mechanism for HIV PR [32] based on kinetic data obtained from solvent 
kinetic isotope effects, pH–rate and O incorporation studies [21, 25]. Combined with 
known previous structural data of HIV PR. In this mechanism, Asp-25 exists in the 
unprotonated state (pKa 3.1) upon binding to substrate, while the proton on Asp-25 (pKa 
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5.2) is positioned to hydrogen bond to the carbonyl oxygen of the substrate, and at the same 
time, the lytic water is positioned closer to the β-carboxylic acid of Asp-25_. This 
mechanism has many similar features in common with the general acid–base mechanism of 
Aspartic proteases reported by other groups [15, 16, 33]. It also resembles in part the 
concerted mechanism proposed by Jaskólski [19] in that the amine product is protonated by 
an active site Aspartyl residue.  
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3. OBJECTIVE OF THE WORK 
The study undertaken in this thesis was part of an ongoing research project, 
This has overall aim of identifying new approach to design HIV-1 Protease inhibitors. 
The Specific objectives of the thesis were: 
•  Prediction of binding energies by various molecular docking methods. 
• Comparison of predicted binding energies to experimental binding energies. 
• Identifying the good molecular docking method among various docking methods. 
• Consensus ranking of enzyme-inhibitor binding in various molecular docking 
methods. 
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4.1. Protein Data Bank (PDB):  
All complexes deposited at PDB with a resolution and R-factor less than 3.0 and 0.2 
respectively, were taken for the study (http://www.rcsb.org/pdb/home/home.do). Twenty-
five HIV-1 protease-inhibitor complexes were taken from Protein Data Bank in the form of 
PDB format. 
 
Table1: For each complex, the PDB code, resolution, R-factor. 
 
S.NO PDB Resolution(A
0
) R-factor 
1 1a9m 2.30 0.185 
2 1aaq 2.50 0.190 
3 1ajv 2.0 0.187 
4 1ajx 2.0 0.161 
5 1gno 2.30 0.17 
6 1g2k 1.95 0.200 
7 1hbv 2.30 0.18 
8 1hih 2.30 0.19 
9 1hiv 2.0 0.17 
10 1hpo 2.50 0.179 
11 1hpv 1.90 0.19 
12 1hpx 2.0 0.170 
13 1hsg 2.0 0.166 
14 1hte 2.80 0.16 
15 1htf 2.20 0.19 
16 1htg 2.00 0.19 
17 1hvh 1.80 0.88 
18 1hvj 2.0 0.158 
19 1hvr 1.80 0.19 
20 1hxw 1.80 0.201 
21 1ida 1.70 0.196 
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22 1qbr 1.80 0.190 
23 1qbt 2.10 0.190 
24 2upj 3.0 0.14 
25 9hvp 2.80 0.18 
 
 
The training set used in this study comprises 25 protein ligand complexes (Table 1). All the 
complexes were taken from the Protein Data Bank (PDB) [35]. Since our interests are 
concentrated on small non-covalently bound ligands, those complexes containing 
covalently bound ligands, complex ligands and macromolecular ligands were stripped out 
of the data set. More than seventy different kinds of proteins are represented in this training 
set and all the structures are of high resolution (better than 3.0 Å). The experimentally 
determined binding data were cited from the literature [35, 36] and expressed in the binding 
energies (table.2). 
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Table.2: Twenty-five HIV-1 Protease-inhibitor binding energies by experimental 
determined and predicted values with RMSD values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.NO PDB Experimental 
Binding Energy 
(kcal/mol) 
cvcvc
1 
1a9m -9.41 
2 1aaq -11.45 
3 1ajv -10.59 
4 1ajx -10.86 
5 1gno -10.57 
6 1g2k -10.81 
7 1hbv -8.68 
8 1hih -10.97 
9 1hiv -12.64 
10 1hpo -11.82 
11 1hpv -12.58 
12 1hpx -12.53 
13 1hsg -12.93 
14 1hte -7.69 
15 1htf -11.04 
16 1htg -13.21 
17 1hvh -10.81 
18 1hvj -14.26 
19 1hvr -12.97 
20 1hxw -14.54 
21 1ida -11.86 
22 1qbr -14.42 
23 1qbt -14.49 
24 2upj -10.14 
25 9hvp -11.38 
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4.2. Chimera: 
UCSF Chimera is a highly extensible, interactive molecular visualization and analysis 
system. Chimera can read molecular structures and associated data in a large number of 
formats, display the structures in a variety of representations, and generate high-quality 
images and animations suitable for publication and presentation. In addition, Chimera 
provides tools to: show density maps and analyze microscopy data; utilize symmetry 
information for the display of higher-order structures; display multiple sequence 
alignments, with crosstalk between the sequences and structures; and enable analysis of 
molecular dynamics trajectories and docking results.  
Molecular Graphics 
• interactively manipulable stick, ball-and-stick, CPK, ribbon, and special nucleotide 
representations; molecular surfaces  
• highly intuitive translation, scaling, and rotation; Side View tool for adjusting 
clipping planes and scaling  
• interactive color editing in various color spaces (RGB, CMYK, etc.), including 
transparency  
• ability to save high-resolution images for presentation and publication  
• stereo viewing (side-by-side and time-sequential)  
Chemical Knowledge 
   
• determination of atom types in arbitrary molecules, including non-standard residues  
• ability to add hydrogen atoms  
• high-quality hydrogen bond identification  
• selection of atoms/bonds by element, atom type, functional group, amino acid 
category  
• interactive bond rotation, distance and angle measurements  
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Fig.7:  Aspartic HIV-1 protease Active site: ASP25-THR26-GLY27   shows in chimera 3D 
protease strcture. 
 
 
 
 
4.3. Various molecular docking methods 
Given recent improvements in search algorithms and energy functions, computational 
docking methods have become a valuable tool to probe the interaction between an enzyme 
and its inhibitors. The interaction energy between the protein and its ligand is calculated by 
a simplified, often grid-based force field [37, 38]. Basic components may include steric and 
electrostatic energies, sometimes supplemented by other terms accounting for hydrogen 
bonding and salvation effects. 
 These methods can contribute significantly to the understanding of structural and energetic 
basis of enzyme-substrate interactions. Protein-ligand docking methods aim to predict the 
binding energy of the protein-ligand complex given the atomic coordinates. In such 
calculations, both the protein and ligand can be treated as rigid bodies [39]. We performed 
protein rigid and ligand flexible docking by autodock4.0, pardock, patchdock and firedock 
methods. Pardock, patchdock and firedock are online docking methods. To judge the 
performance of any approach for prediction of binding energy and consensus ranking, it is 
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important to consider the various types of docking methods and scoring functions used. 
Computationally top-scoring solutions taken a selection from among the top scoring 
solution (e.g. the one closest to the experimental data among the ten top solutions) or 
simply the solution closest to the experimental data[40] (easiest and least rigorous 
approach). The accurate prediction of enzyme-substrate interaction energies is one of the 
major challenges in computational biology. Generally various docking methods followed 
by various energy scoring functions. 
     We performed various Molecular Docking simulations on HIV-1 protease-inhibitor 
complexes and using the resulting structures to calculate the binding energies by AutoDock 
4.0 and online molecular docking tools pardock, patchdock and firedock programs. 
Autodock and pardock produced binding free energy of enzyme-inhibitor and global 
energy produced by firedock, which is binding free energy of solution.Complementarity 
score produced by patchdock. Common top ranked docking solutions in autodock and 
pardock showed that good binding in molecular interaction. Hence consensus scoring or 
ranking of top ten solutions become a good binding in molecular interactions in these 
methods. The consensus ranking of enzyme-inhibitor complexes in various molecular 
docking methods improve the binding energy predictions. Consensus ranking has become 
an important method in various molecular docking methods to identify new inhibitors in 
computer-assisted discovery of new pharmaceutics. 
4.4. Autodock 4.0  
AutoDock is a suite of automated docking tools. It was designed to predict how small 
molecules, such as substrates or drug candidates, bind to a receptor of known 3D structure. 
AutoDock actually consists of two main programs: AutoDock performs the docking of the 
ligand to a set of grids describing the target protein [41]; Auto Grid pre-calculates these 
grids. In additions to using them for docking, the atomic affinity grids can be visualized. 
This can help, for example, to guide organic synthetic chemists design better binders. 
autodock tools, or ADT developed a graphical user interface called for short, which 
amongst other things helps to set up which bonds will treated as rotatable in the ligand and 
to analyze dockings. 
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4.4.1 AutoDock has applications in 
• X-ray crystallography  
• structure-based drug design 
• lead optimization 
• virtual screening (HTS)  
• combinatorial library design  
• protein-protein docking  
• Chemical mechanism studies. 
AutoDock is used to perform computational molecular docking of small molecules to 
proteins, DNA, RNA and other important macromolecules, by treating the ligand and 
selected parts of the target as conformationally flexible. It uses a scoring function based on 
the AMBER force field, and estimates the free energy of binding of a ligand to its target. 
Novel hybrid global-local evolutionary algorithms are used to search the phase space of the 
ligand-macromolecule system.  
The introduction of AutoDock 4 comprises three major improvements: 
1. The docking results are more accurate and reliable.  
2. It can optionally model flexibility in the target macromolecule.  
3. It enables AutoDock's use in evaluating protein-protein interactions. 
AutoDock 4.0 not only is it faster than earlier versions, it allows side chains in the 
macromolecule to be flexible.  As before, rigid docking is blinding Gly fast, and high-
quality flexible docking can be done in around a minute. Up to 40,000 rigid dockings can 
be done in a day on one CPU.AutoDock 4.0 now has a free energy scoring function that is 
based on a linear regression analysis, the AMBER force field, and an even larger set of 
diverse protein-ligand complexes with known inhibition constants than we used in 
AutoDock 3.0. The best model was cross validated with a separate set of HIV-1 protease 
complexes, and confirmed that the standard error is around 2.5 kcal/mol. This is enough to 
discriminate between leads with milli-, micro- and nano-molar inhibition constants. 
AutoDock 4.0 can be compiled to take advantage of new search methods from the 
optimization library, ACRO, developed by William E. Hart at Sandia National Labs.  We 
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have also added some new features to our existing evolutionary methods.  We still provide 
the Monte Carlo simulated annealing (SA) method of 2.4 and earlier.  The Lamarckian 
Genetic Algorithm (LGA) is a big improvement on the Genetic Algorithm, and both 
genetic methods are much more efficient and robust than SA. 
4.4.2 AutoDockTools (ADT) 
We have developed and continue to improve our graphical front-end for AutoDock and 
AutoGrid, ADT (AutoDockTools). It runs on Linux, Mac OS X, SGI IRIX and Microsoft 
Windows. AutoGrid is a program that pre-calculates grid maps of interaction energies for 
various atom types, such as aliphatic carbons, aromatic carbons, hydrogen-bonding oxygen, 
and so on, with a macromolecule such as a protein, DNA or RNA. These grid maps were 
then used by autodock docking calculations to determine the total interaction energy for a 
ligand with a macromolecule. Doing this pre-calculation saves a lot of time during the 
docking, primarily because we do not have to update non-bonded lists during the 
calculation. In addition, what was a calculation with order N-squared complexity is reduced 
to one that is order N, where N is the number of atoms interacting.  
AutoDock 4 offers many new features and improvements over previous versions. The most 
significant is that it models flexible side chains in the protein. We have recalibrated the free 
energy scoring function using a much larger training set of ligand-protein complexes. We 
can get both the 3D structure and the inhibition constants, Ki. There are also new search 
methods. 
Many limitations of version 3 have been removed in AutoDock 4. One of biggest 
annoyances was the limit of 6 different atom types in a ligand; this has been increased to 
22, and the method of specifying atom types is improved, using a single parameter file 
called "AD4_parameters.dat" by default. In addition, autodock 4 no longer requires the user 
to set the stack size to unlimited in the UNIX shell. 
 
4.4.3 Importance of Autodock 
It is very fast, provides high quality predictions of ligand conformations, and good 
correlations between predicted inhibition constants and experimental ones. AutoDock has 
also been shown to be useful in blind docking where the location of the binding site is not 
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known.  Autodock4.0 introduces the ability to model conformational flexibility in selected 
side chains in the target macromolecule; it uses a new desolvation energy term and was 
calibrated on a set of 188 ligand-protein complexes of known structure and binding 
affinity. There have been numerous improvements made to the search algorithms and the 
molecular representation of the problem, and autodock supports more atom types than 
previous versions. Thanks to ADT, a very refined graphical user interface, autodock has 
been made easier to use than earlier versions, allowing bench chemists and other non-
computational chemists to set up dockings and analyse the results visually. 
4.4.4 AutoDock4 scoring functions  
• van der Waals  
• Hydrogen Bonding  
• Electrostatics  
• Desolvation 
• Torsional  
Binding energy=Intermolecular energy+Torsional energy  
∆Gbind = ∆Gvdw + ∆Gele.  + ∆GH-bond + ∆G desolv +∆Gtors  
 Here ∆G=change in free energy 
 
AutoDockTools, or ADT, is the ultimate GUI to set up, launch and analyze AutoDockruns. 
View molecules in 3D, rotate & scale in real time.  
• Add all hydrogen’s or just non-polar hydrogen’s.  
• Assign partial atomic charges to the ligand and the macromolecule (Gasteiger or 
Kollman United Atom charges).  
• Merge non-polar hydrogen’s and their charges with their parent carbon atom.  
• Set up rotatable bonds in the ligand using a graphical version of AutoTors.  
• Set up the AutoGrid Parameter File (GPF) using a visual representation of the grid 
box, and slider-based widgets.  
• Set up the AutoDock Parameter File (DPF) using forms.  
• Launch AutoGrid and AutoDock.  
• Read in the results of an AutoDock job and graphically display them.  
• View is contoured AutoGrid affinity maps.  
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4.5. Pardock  
This program all-atom energy based Monte Carlo docking procedure tested on a dataset of 
226 protein-ligand complexes [36]. Average root mean square deviation (RMSD) from 
crystal conformation was observed to be ~ 0.53 Å. The correlation coefficient (r2) for the 
predicted binding free energies calculated using the docked structures against experimental 
binding affinities was 0.72. The docking protocol is web-enabled as free software at 
(www.scfbioiitd.res.in/dock) ParDOCK will predict the binding mode of the ligand 
conforming to the following format and other requirements: 
 
4.5.1 Online procedure: 
1. Upload hydrogen added Protein Reference Complex and Candidate Molecule in 
PDB format.  
2. Please make sure that Protein Reference Complex contains the Drug information to 
perform docking.  
3. Enter Formal Charge between +10 to -10. If no charge is entered, '0' will be 
assigned by default.  
4. Specify your email Id in text box. As the program might take 15-20 minutes to 
process the query, result will be e-mailed to you. If you do not specify any email id, 
Job ID that is provided at each submission can retrieve result. The job ID can also 
be used to check the status of your job.  
5. Click Run to submit the job. If other jobs are running on the server, your job will be 
put in queue and Job Status will be shown to you.  
4.5.2 PDB format 
the input file should be in the 'AMBER' PDB format i.e., as described here   
1. There is a slight difference in the format for Protein Reference Complex and drug, 
as per PDB convention, this is shown below.  
2. The spacing between columns is not important but two columns should NOT merge 
at any place.  
The structural inputs for ParDOCK are a reference complex (target protein bound to a 
reference ligand) and a candidate molecule. Fig.8 shows the flowchart of docking 
methodology adopted. The ParDOCK protocol consists of four main steps: (a) 
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identification of the best possible grid/ translational points in radius of 3Å around the 
reference point (centre of mass);(b) generation of protein grid and preparation of energy 
grid in and around the active site of the protein to pre-calculate the energy of each atom in 
the candidate ligand; (c) Monte Carlo docking and intensive configurational search of the 
ligand inside the active site; and (d) identification of the best docked structures on an 
energy criterion and prediction of the binding free energy of the complex. 
This completely automated version of ParDOCK was developed for finding the binding 
mode of the ligand to its receptor to a known binding site and not for predicting all possible 
binding sites. The reference complex therefore helps in initiating the search. For the sake of 
efficiency, a portion of the receptor enclosing the binding site is considered and this 
simplification was accounted for in atomic level energy calculations. Goodford pioneered 
the use of grids for docking protocols and we have used grid representations for energy 
calculations. The basic idea is to store information about the receptor’s energy 
contributions on grid points so that only these need to be read during scoring. 
 
 
4.5.3 Methodology 
1. Identification of the Grid / Translation Points 
The center of mass (COM) of the reference ligand is calculated and considered as a 
reference point inside the active site of the protein. A cube of length 6Å (i.e. ± 3Å) with 
respect to the reference point is created and a uniform grid of length 1Å inside the 6Å cube 
is defined. The 1Å grids occupied by protein atoms are eliminated and the free grid points 
are considered. This helps to increase the efficiency of search by providing all possible 
translational points in a decreased/ vacant search space. 
2. Generation of Protein Grid and Pre-Calculation of Energy 
Protein grid of length 10Å is generated in order to identify the protein residues interacting 
with the candidate ligand. The protein grid formation helps in identifying the protein 
residues in a specified range, which are interacting with atoms of the candidate ligand. 
While searching for the spatial positions around the reference point (COM) within the 
active site of the protein, the clash module helps in identifying the appropriate translation 
points from the given series of points in the range of 1Å. Number of clashes is calculated at 
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each translation point and the best set of translation points with minimum number of 
clashes are selected in the given cube of length 6Å. 
The energy grid was arranged in and around the active site of the protein based on the 
selected translation points and the energy points were placed at equal distance inside the 
grid. The interaction energy of each atom of the candidate ligand was pre-calculated at each 
point using a scoring function comprising three components: electrostatic, van der Waals 
and hydrophobic interactions. For a given energy point, a cube cut off is fixed and the 
protein atoms interacting with this point are identified. 
3. Generation of Monte Carlo Configurations of the Ligand 
The Monte Carlo configurations are generated around six degrees of freedom, which result 
in many combinations of ligand configurations at each translation point. For each Monte 
Carlo configuration, energy points were selected and pre-calculated energies of each atom 
are added. The putative binding configurations were selected based on the scoring function. 
4. Preparation of Protein and Ligand for Docking 
The complexes chosen for study are adapted from RCSB and prepared in a force field 
compatible manner. Initially the crystallographic water molecules were removed and the 
ligand coordinates are extracted from the protein-ligand complex. Hydrogen atoms were 
added keeping the ionization states of the atoms in the ligand as specified in the literature. 
The ligand is then geometry optimized Through AM1 procedure followed by calculation of 
partial charges of the ligand by AM1-BCC procedure. GAFF force field was used to assign 
atom types, bond angle, dihedral and van der Waals parameters for the ligand. 
5. Description of All-Atom Energy Based Scoring Function 
The ligand configurations generated were ranked based on an all atom energy function, 
which calculates non-bonded interactions of protein-ligand complexes as described in 
equation (I). 
E = ∑ Eel + Evdw + Ehpb (I)  
E is the total non-bonded energy, Eel is the electrostatic contribution to the energy, Evdw is 
the van der Waals term, Ehpb is the hydrophobic term and the summation runs over all the 
atoms of the protein-ligand complex. Electrostatic contribution is calculated by Coulomb’s 
law with sigmoidal dielectric function, van der Waals term is computed using a (12, 6) 
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Lennard-Jones potential between the atoms of protein and ligand and hydrophobic 
interactions are calculated by Gurney parameter approach. 
6. Energy Minimization of Docked Structures and Protein- Ligand Binding Free 
Energy Estimations 
The selected docked complexes are energy minimized in vacuum by AMBER. For vacuum 
minimizations, 1000 steps of steepest descent and 1500 steps of conjugate gradient was 
carried out. The minimization procedure was repeated using explicit solvent, without much 
difference in the calculated energetics. Hence, the vacuum minimization protocol was 
retained due to its expeditious nature. The energy-minimized structure was employed in 
computing the binding affinity by a scoring function, BAPPL. The energy function 
employed in BAPPL includes contributions of electrostatics, van der Waals, 
hydrophobicity and loss of conformational entropy of protein side chains upon ligand 
binding. 
 
 
Fig.8. Pardock methodology 
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4.5.4 Prdock procedure: 
1. Center of mass (COM) the reference ligand is calculated 
2. The grid is made in the radii of 6A0  around the COM of the reference ligand 
 3. A grid length of 1A0 box inside 6A0 cube was made and each center point of 1A0 box 
was considered as a   translation point. 
4. Selected translation points were shown after eliminating some of the points using clash 
module. 
5. Grid generated for the whole protein by 10A0 length 
         6. Based on selected translation point’s energy grid was made at equal distance and pre 
energy calculation of each ligand atom at each energy point is calculated. 
7. Generation of Monte Carlo configurations by six degrees of freedom 
8. The energy of each configuration was matched with the energy points and the pre-calculated 
energies were added. 
9. The best energy structure was selected based on energy points 
10. The RMSD difference between crystal structure and energy minimized docked 
structure. 
4.6. PatchDock 
Patchdock [43] is a molecular docking algorithm based on shape complementarity 
principles. It aimed at finding docking transformations that yield good molecular shape 
complementarity. Such transformations, when applied, induce both wide interface areas 
and small amounts of steric clashes. A wide interface ensured to include several matched 
local features of the docked molecules that have complementary characteristics. The 
PatchDock algorithm divides the Connolly dot surface representation of the molecules into 
concave, convex and flat patches [44, 45]. Then, complementary patches matched in order 
to generate candidate transformations. Each candidate transformation further evaluated by a 
scoring function. 
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That considers both geometric fit and atomic desolvation energy [46]. Finally, an RMSD 
(root mean square deviation) clustering was applied to the candidate solutions to discard 
redundant solutions. The main reason behind PatchDock’s high efficiency is its fast 
transformational search, which was driven by local feature matching rather than brute force 
searching of the six-dimensional transformation space. It further speeds up the 
computational processing time by utilizing advanced data structures and spatial pattern 
detection techniques, such as geometric hashing and pose clustering that were originally 
developed in the field of computer vision. The run time of PatchDock for two input 
proteins of average size (about 300 amino acids) is <10 min on a single 1.0 GHz PC 
processor under the Linux operating system. 
4.6.1 The patchdock web server: input, output and user interface 
It was developed a very simple and intuitive web interface for the PatchDock algorithm 
available at http://bioinfo3d.cs. tau.ac.il/PatchDock/. Once the docking request is 
submitted, the PatchDock algorithm starts the prediction process. The user is notified when 
the results are ready by an email message that contains a link to a web page where the 
predictions are presented. On this page, the user can both view specific predictions and 
download a compressed file of the top scoring solutions (see Figure 9). 
 
Fig.9: patchdock input file 
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Fig.10: patchdock output file 
 
 
The PatchDock user interface (fig.9) the request form of PatchDock. The receptor molecule 
and the ligand molecule are given either by the PDB code of the molecule (chain IDs are 
optional) or by uploading a file in PDB format. (fig.10) the solutions page presents the 
geometric score, interface area size and desolvation energy of the 20 top scoring solutions. 
The user can use the ‘show next 20’ button to view solutions of lower score. The user can 
download each solution by pressing the solution link in the rightmost column or download 
an archive file (ZIP format) of the best solutions using the action button at the bottom of 
the page. 
4.6.2 Molecular Docking Algorithm Based on Shape Complementarity Principles 
PatchDock is an algorithm for molecular docking. The input is two molecules of any type: 
proteins, DNA, peptides, drugs. The output is a list of potential complexes sorted by shape 
complementarity criteria.  
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Short Overview: PatchDock algorithm was inspired by object recognition and image 
segmentation techniques used in Computer Vision. Docking was compared to assembling a 
jigsaw puzzle. When solving the puzzle we try to match two pieces by picking one piece 
and searching for the complementary one. PatchDock employs a similar technique. Given 
two molecules, their surfaces were divided into patches according to the surface shape. 
These patches correspond to patterns that visually distinguish between puzzle pieces. Once 
the patches were identified, they can be superimposed using shape matching algorithms. 
The algorithm has three major stages:  
• Molecular Shape Representation - In this step, we compute the molecular surface 
of the molecule. Next, we apply a segmentation algorithm for detection of 
geometric patches (concave, convex and flat surface pieces). The patches were 
filtered, so that only patches with 'hot spot' residues were retained.  
Fig.11: Molecular Shape Representation 
 
 
• Surface Patch 
Matching - we apply a hybrid of the Geometric Hashing and Pose-Clustering 
matching techniques to match the patches detected in the previous step. Concave 
patches were matched with convex and flat patches with any type of patches.  
• Filtering and Scoring - the candidate complexes from the previous step were 
examined. We discard all complexes with unacceptable penetrations of the atoms of 
the receptor to the atoms of the ligand. Finally, the remaining candidates were 
ranked according to a geometric shape complementarity score.  
4.7. FireDock 
 The FireDock [47] server addresses the refinement problem of protein-protein docking 
solutions. The method simultaneously targets the problem of flexibility and scoring of 
solutions produced by fast rigid-body docking algorithms. Given a set of up to 25 potential 
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docking candidates, FireDock refines and scores them according to an energy function, 
spending about 3.5 seconds per candidate solution. To the best of our knowledge, this is 
the first web server that allows performing large-scale flexible refinement and scoring of 
docking solutions online.  
4.7.1 Input files 
There are two input options for FireDock. In the first option, the user uploads/specifies 
PDB codes of two PDB files (receptor and ligand) and provides a list of transformations. 
Each transformation, when applied on the ligand, produces a candidate docking solution. 
In the second option, the user can upload an input PDB file, with each docking solution 
represented by a MODEL. The candidate solutions for FireDock can be generated by 
rigid-body docking methods, such as Patchdock [48, 49], FFT-based methods such as 
ZDOCK, GRAMM-X, Hex, ClusPro etc. In addition, we provide an option for automatic 
redirection of solutions from PatchDock web server. 
 
Each candidate is subsequently refined by restricted interface side-chain rearrangement and 
by soft rigid-body optimization. The side-chain flexibility was modeled by rotamers and 
integer linear programming [50] solves the obtained combinatorial optimization problem. 
Following rearrangement of the side-chains, the relative position of the docking partners is 
refined by Monte Carlo minimization of the binding score function. The binding score rank 
the refined candidates. This score includes Atomic Contact Energy [51], softened van der 
Waals interactions, partial electrostatics and additional estimations of the binding free 
energy.  
4.7.2 Output files 
The output is a ranked list of all the input solutions. The refined complex structure is 
generated for up to 100 low-energy candidates. The user can view the complexes in the 
Jmol applet window and/or download the structures.   
The figure below shows an example of FireDock usage. Transformations of docking 
candidates are generated by PatchDock [48, 49] and are given as an input to FireDock. First 
a coarse refinement is performed, using a restricted interface side-chain optimization with 
atomic radii scaling of 0.8, in order to allow a certain amount of steric clashes. The refined 
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candidates are scored and ranked according to the energy function and are returned as an 
output. Then, FireDock is run again on the best 25 solutions for a final refinement. In this 
second run, a full interface side-chain optimization is performed with atomic radii scaling 
of 0.85, in order to reduce the amount of clashes.  
Fig.12: firedock output  
 
 
4.7.3 Firedock scoring parameters: 
Program parameters for score calculation for different complex types. Parameters are 
specified for the full and coarse refinement stages. The parameters described in the table 
are weights of the following scoring terms: 
• attrV dWWeight - softened attractive van der Waals interactions 
• repV dWWeight - softened repulsive van der Waals interactions 
• attrElWeight - attractive short-range Coulomb electrostatics 
• repElWeight - repulsive short-range Coulomb electrostatics 
• l attrElWeight - attractive long-range Coulomb electrostatics 
• l repElWeight - repulsive long-range Coulomb electrostatics 
• ACEWeight - Atomic Contact Energy (ACE) potential 
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• HBWeight - hydrogen and disulfide Bonds 
• catpiWeight - cation-_ stacking 
• pipiWeight - _-_ stacking 
• aliphWeight - aliphatic interactions 
• insidenessWeight - “insideness” measure 
• confProbWeight - internal energy 
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5.1. Binding energy prediction by Autodock 4.0 
Ligand all-atom RMSD (Å) and the number of docking solutions (N) in the cluster from 
100 Lamarckian genetic algorithm (LGA) docking with lowest binding energy of each 
solution was top ranked solutions was selected(table.3). Moreover, Monte Carlo Docking 
Protocol runs for twenty-five protease-inhibitor complexes (Morris GM et al. 1998). 
Table 3: For each complex, the lowest binding energy and RMSD evaluated by autodock. 
 
S.NO PDB Autodock 4.0 
Binding Energy 
(kcal/mol) 
RMSD(A0) N 
1 1a9
m 
-9.84       1.30 30 
2 1aaq -9.45       1.65 33 
3 1ajv -11.46       0.74 37 
4 1ajx -10.02       1.57 19 
5 1gno -12.19      1.73 6 
6 1g2k -7.53       0.00 39 
7 1hbv -9.04 1.92 96 
8 1hih -9.34       1.94 21 
9 1hiv -11.47 1.98 19 
10 1hpo -9.22 0.68 39 
11 1hpv -9.87       1.76 45 
12 1hpx -11.88 1.41 30 
13 1hsg -11.16       1.24 25 
14 1hte -7.54       1.95 22 
15 1htf -19.60       0.74 34 
16 1htg -13.29 1.22 80 
17 1hvh -8.03       0.01 5 
18 1hvj -10.03 1.80 48 
19 1hvr -14.80       0.13 16 
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20 1hx
w 
-10.04       0.82 49 
21 1ida -12.64       1.36 21 
22 1qbr -14.59       1.74 40 
23 1qbt -14.41       1.82 4 
24 2upj -10.20       1.46 13 
25 9hvp -11.43       1.71 53 
 
Number of docking solutions in a cluster (N): Table.3 shows the number of docking 
solutions in a cluster (N) along with the all atom ligand RMSD for each docking solution. 
A small N value indicates strong specificity of binding, on average, the lower number of 
docking solutions in the cluster for all docking simulation indicates that the ligands bind to 
their binding pocket with high specificity, with all of the solutions resembling one of only a 
small number of binding conformations and orientations. On the other hand, if N is large, 
the experiment indicates a low specificity of binding, since the solutions are composed of 
many different binding conformations/orientations.  
Average all-atom root mean square deviations (RMSD): 
Table.3 shows the all atom RMSD between each simulated complex and the corresponding 
protease-inhibitor x-ray structure. The best results were obtained from the structures in 
pardock than autodock. These structures also have low (≅ 0.35 Å) average all-atom root 
mean square deviations (RMSD) relative to the experimental results (table.4). The average 
RMSD for the complexes docked using autodock4.0 were found to be ≅ 1.3 Å. 
 
5.2. Binding energy prediction by Pardock 
For each complex, the lowest binding energy and RMSD evaluated by pardock with  Monte 
Carlo Docking Protocol runs for twenty-five protease-inhibitor complexes (Gupta et al.  
2007). 
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Table.4: For each complex, the lowest binding energies and RMSD evaluated by pardock. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.NO PDB ParDock RMSD(A0) 
1 1a9m -11.32 0.70 
2 1aaq -11.21 0.271 
3 1ajv -10.94 0.210 
4 1ajx -10.26 0.434 
5 1gno -10.10 0.290 
6 1g2k -12.13 0.370 
7 1hbv -10.91 0.442 
8 1hih -11.80 0.204 
9 1hiv -13.14 0.344 
10 1hpo -11.14 0.388 
11 1hpv -10.83 0.189 
12 1hpx -13.18 0.416 
13 1hsg -12.49 0.347 
14 1hte -8.06 0.219 
15 1htf -9.99 0.253 
16 1htg -12.86 0.440 
17 1hvh -12.18 0.454 
18 1hvj -15.02 0.206 
19 1hvr -12.96 0.195 
20 1hxw -14.60 0.327 
21 1ida -12.55 0.327 
22 1qbr -14.54 0.331 
23 1qbt -14.61 0.447 
24 2upj -10.70 0.493 
25 9hvp -13.90 0.515 
 42 
 
5.3. Complementarily score and binding energy prediction by patchdock and firedock 
The PatchDock algorithm divides the Connolly dot surface representation of the molecules 
into concave, convex and flat patches. Then, complementary patches were matched in order 
to generate candidate transformations. Each candidate transformation was further evaluated 
by a scoring function that considers both geometric fit and atomic desolvation energy. 
Finally, an RMSD (root mean square deviation) clustering was applied to the candidate 
solutions to discard redundant solutions. The total complementarity score was produced in 
enzyme-inhibitor binding state.  Top score solutions became the top ranked solutions were 
selected for each enzyme-inhibitor complex among 100 solutions (Table.5). 
Firedock was produced global energy (binding energy) of enzyme-inhibitor binding state. 
Which is selected top ranked with lowest gobal energy of solution from top 10 
solutions.which is followed by patchdock program.firedock was designed based on various 
scoring functions.we considered as global energy of each solution was divided by 5.55 
factor  which became a binding energy of each solution. The relation was generated 
between global energy and the binding energy in firedock solutions as follows 
Firedock binding energy = firedock global energy/5.55 
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Table.5: Firedock and patchdock results 
S.NO PDB Firedock 
Global energy 
Firedock  
Binding energy *5.55 
Patchdock 
Score 
1 1a9m -51.66 -9.31 8186 
2 1aaq -48.76   -8.78 8404 
3 1ajv -61.94 -11.16 8148 
4 1ajx -54.20 -9.76 8354 
5 1gno -87.37 -15.74 11084 
6 1g2k -62.16 -11.20 8462 
7 1hbv -64.97 -11.70 8874 
8 1hih -60.25 -10.85 8722 
9 1hiv -57.19 -10.30 10042 
10 1hpo -42.95 -7.74 6428 
11 1hpv -51.56 -9.29 7604 
12 1hpx -56.75 -10.22 8522 
13 1hsg -58.43 -10.53 8342 
14 1hte -38.38 -6.91 5912 
15 1htf -92.77 -16.71 10250 
16 1htg -132.58 -23.89 10002 
17 1hvh -52.39 -9.44 8014 
18 1hvj -59.72 -10.76 8836 
19 1hvr -67.03 -12.08 8854 
20 1hxw -67.64 -12.19 8716 
21 1ida -64.09 -11.55 9232 
22 1qbr -78.55 -14.15 9486 
23 1qbt -82.05   -14.78 9896 
24 2upj -52.67 -9.49 7864 
25 9hvp -74.88 -13.49 10292 
Average:              -64.84                 -11.68                    8741 
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5.4.  Comparison of binding energies  
For each complex, the lowest binding energies evaluated by autodock, pardock, firedock 
and complementarities score predicted by patchdock programs. The differences between 
average experimental binding energies to predicted average binding energies in autodock, 
pardock and firedock were 0.55, 0.35 and 0.02. It was clearly illustrated that pardock 
binding energies are very near to experimental values with a difference 0.35. And  firedock 
binding energy values are very near to experimental binding energy values with a 
difference 0.02 (if we considered as 5..55 multiple factor to predicted binding energy  
values). Patchdock was produced average score for all twenty-five complexes were 8741. 
The solutions with greater/equal to the average score were observed good binding solutions 
in enzyme-inhibitor binding process. 
 
Table.6: comparison of binding energies  
 
S.NO PDB Experimental 
Binding 
Energy 
(kcal/mol) 
Autodock 4.0 
Binding 
Energy 
(kcal/mol) 
Pardock 
Binding Energy 
(kcal/mol) 
Firedock 
Global 
Energy 
*5.55 
Patchdock 
Score 
1 1a9m -9.41 -9.84       -11.32 -9.31 8186 
2 1aaq -11.45 -9.45       -11.21 -8.78 8404 
3 1ajv -10.59 -11.46       -10.94 -11.16 8148 
4 1ajx -10.86 -10.02       -10.26 -9.76 8354 
5 1gno -10.57 -12.19      -10.10 -15.74 11084 
6 1g2k -10.81 -7.53       -12.13 -11.20 8462 
7 1hbv -8.68 -9.04 -10.91 -11.70 8874 
8 1hih -10.97 -9.34       -11.80 -10.85 8722 
9 1hiv -12.64 -11.47 -13.14 -10.30 10042 
10 1hpo -11.82 -9.22 -11.14 -7.74 6428 
11 1hpv -12.58 -9.87       -10.83 -9.29 7604 
12 1hpx -12.53 -11.88 -13.18 -10.22 8522 
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13 1hsg -12.93 -11.16       -12.49 -10.53 8342 
14 1hte -7.69 -7.54       -8.06 -6.91 5912 
15 1htf -11.04 -19.60       -9.99 -16.71 10250 
16 1htg -13.21 -13.29 -12.86 -23.89 10002 
17 1hvh -10.81 -8.03       -12.18 -9.44 8014 
18 1hvj -14.26 -10.03 -15.02 -10.76 8836 
19 1hvr -12.97 -14.80       -12.96 -12.08 8854 
20 1hxw -14.54 -10.04       -14.60 -12.19 8716 
21 1ida -11.86 -12.64       -12.55 -11.55 9232 
22 1qbr -14.42 -14.59       -14.54 -14.15 9486 
23 1qbt -14.49 -14.41       -14.61 -14.78 9896 
24 2upj -10.14 -10.20       -10.70 -9.49 7864 
25 9hvp -11.38 -11.43       -13.90 -13.49 10292 
Average :             -11.70                -11.15                -12.05                    -11.68            8741 
 
5.5. Correlation between experimentally determined and calculated Binding energy 
The primary objective of this study was to determine the binding energies by various 
docking methods and compared with experimental binding energies (table.6). Moreover, 
Table.7 shows the correlation coefficient of the experimentally determined and calculated 
binding energies from AutoDock 4.0 for the twenty-five protease-inhibitor complexes after 
protein rigid ligand flexible docking was 0.484 and the correlation coefficient from pardock 
was 0.801. 
Table.7: correlation between experimental to predicted binding energies in autodock and 
pardock. 
SNO Docking 
method 
Correlation coefficient  Correlation 
initial After removed 
one outlier 
initial After  removed 
one outlier 
1 Autodock4.0 0.484 0.488 0.696 0.698 
2 Pardock 0.801 0.841 0.895 0.917 
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Experimentally determined vs. calculated binding energies for the twenty-five HIV-1 
protease-inhibitor complexes 
Plot 1: Graphs were plotted between experimental and predicted binding energies by 
Autodock 4.0 program. Correlation coefficient is 0.484(plot.1.a), changed to 0.488(plot.1.b) 
after outlier (9hvp) is eliminated in autodock4.0. 
 
 
Plot 2: Graphs were plotted between experimental and predicted binding energies by 
Pardock program. Correlation coefficient is 0.801(plot.2.a), changed to 0.841(plot.2.b) after 
outlier (9hvp) is eliminated in pardock. 
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The best correlation coefficient 0.841 was observed in the pardock method after one outlier 
eliminated from the plots. The 1hiv predicted binding energy values are -11.47 kcal/mol in 
autodock,-13.14 kcal/mol in pardock. The 1hiv average predicted binding energy values in 
autodock and pardock was -12.30 kcal/mol, which is approximately equal to 1hiv 
experimental binding energy value -12.64 kcal/mol (table.6). The average binding energy 
value of these two predicted methods is approximately equal to its experimental binding 
energy value. The 1hiv shows consensus rank in autodock and pardock methods. 
Patch dock score: 
• Patchdock score ≥ 8741 having good binding solutions  were observed(R≈0.82) 
• 11 HIV-1PR-Inhibitor complexes having patchdock score ≥ 8741  out of 25 
• Having Correlation (R)is ≈0.82for 11 HIV-1PR-Inhibitor complexes in pardock  
 
 
 
 
 
 
 
 
                       Plot.3: Patchdock score ≥ 8741 for 11 complexes. 
  
Comparison of Average binding energy value: 
 In this study, the average experimental binding energy value for twenty-five HIV-1 
Protease-inhibitor complexes shows -11.70 kcal/mol. which is approximately equal to the 
average of average predicted binding energy values of autodock and pardock was -11.60 
kcal/mol (Fig.13). it is clearly indicates that consensus ranking of enzyme-inhibitor binding 
energy values in autodock and pardock methods are highly correlated to experimental 
binding energy values.  
Here -11.70 is average experimental binding energy value and -11.60 are average of 
average predicted binding energy values in autodock and pardock method. 
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Fig.13: Ven diagram: consensus ranking of enzyme-inhibitor binding energy in both 
autodock and pardock.(In our study 1hiv complex consensus ranked on the trend lines in 
the plots). 
 
 
 
In this study, the average experimental binding energy value for twenty-five HIV-1 
Protease-inhibitor complexes shows -11.70 kcal/mol. Which is approximately equal to the 
average of average, predicted binding energy values of autodock, pardock and firedock was 
-11.63 kcal/mol (Fig.14). it is clearly indicates that consensus ranking of enzyme-inhibitor 
binding energy values in autodock, pardock and firedock methods are highly correlated to 
experimental binding energy values. 
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Fig.14: Ven diagram: consensus ranking of enzyme-inhibitor binding energy in autodock, 
pardock and firedock. (In our study 1hiv complex consensus ranked on the trend lines in 
the plots). 
 
 
 
Here -11.70 is average experimental binding energy value and -11.60 are average of 
average predicted binding energy values in autodock and pardock. -11.86 and -11.41 are 
average of average predicted binding energy in pardock, firedock and autodock, firedock 
methods. 
-11.63 is average of average predicted binding energy values in autodock, pardock and 
firedock,which is approximately equal to -11.70(average experimental binding energy 
values). 
 
When a constant value 2.0 added to the predicted energies after docking with pardock, the 
binding energies of almost of the predictions were within -10 kcal/mol of the experimental 
values. Among these, 1hvr, 1hiv, 2upj are matched on the trend line in the plots between 
experimental and predicted binding energies in both autodock and pardock programs. 
firedock predicted binding energy values were very near to experimental binding energy 
values if 5.55 factor is multiple for the predicted binding energy values 
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6. CONCLUSIONS 
In this study, we illustrate the importance of considering various docking methods to 
predict the structure and energetic of protein-ligand interactions. It is clear that pardock 
method for molecular docking simulations is produced good correlations between 
calculated and experimental binding energies. The average binding energy values of these 
two predicted methods was approximately equal to its average experimental binding energy 
value. Moreover, the average binding energy values of autodock, pardock and firedock 
predicted methods are approximately equal to its experimental binding energy value. The 
1hiv shows consensus rank in autodock, pardock and firedock methods. The consensus 
ranking of enzyme-inhibitor complexes in various docking methods improve the binding 
energy predictions. One among twenty-five enzyme-inhibitor complexes, 1hiv shows 
consensus rank in autodock, pardock and firedock methods. Three (1hvr, 1hiv and 2upj) 
enzyme-inhibitor complexes were observed in the plots of both autodock and pardock with 
more precision. The differences in these correlations may reflect various energy functions 
in different docking methods and biological features of the interactions of HIV-1 protease-
inhibitor complexes. This approach will be helpful in computer assisted drug design. 
 
FUTER WORK 
Future work with larger data sets, various energy functions, various docking and binding 
energy evaluation methods, and more starting seeds, is necessary to determine the optimal 
parameters to robustly predict protein substrate binding energies in silico. 
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